TSCAN THERAPEUTICS INC's ticker is and the CUSIP is 89854M101. A total of 25 filers reported holding TSCAN THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DC Funds, LP | 630,000 | $976,500 | 26.44% |
| Deer Management Co. LLC | 1,245,505 | $1,930,533 | 0.18% |
| TANG CAPITAL MANAGEMENT LLC | 514,655 | $797,715 | 0.12% |
| Alphabet Inc. | 1,077,080 | $1,647,932 | 0.10% |
| Newtyn Management, LLC | 230,000 | $374,900 | 0.08% |
| DC Investments Management, LLC | 35,563 | $55,123 | 0.07% |
| Baker Brothers Advisors | 2,784,792 | $4,316,428 | 0.03% |
| Privium Fund Management (UK) Ltd | 15,825 | $24,529 | 0.02% |
| Tekla Capital Management LLC | 200,000 | $326,000 | 0.01% |
| NewEdge Wealth, LLC | 91,463 | $141,768 | 0.01% |